ADIL

Adial Pharmaceuticals, Inc - Common Stock (ADIL)

About Adial Pharmaceuticals, Inc - Common Stock (ADIL)

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Details

Daily high

$1.49

Daily low

$1.40

Price at open

$1.45

52 Week High

$18.90

52 Week Low

$1.38

Market cap

2.0M

Dividend yield

0.00%

Volume

122,801

Avg. volume

103,879

P/E ratio

-.08

Adial Pharmaceuticals, Inc - Common Stock News